Author:
Ben Hassen Céline,Gutierrez-Pajares Jorge L.,Guimaraes Cyrille,Guibon Roseline,Pinault Michelle,Fromont Gaëlle,Frank Philippe G.
Abstract
Abstract
Background
The highest incidence of breast cancer is in the Western world. Several aspects of the Western lifestyle are known risk factors for breast cancer. In particular, previous studies have shown that cholesterol levels can play an important role in the regulation of tumor progression.
Methods
In the present study, we modulated cholesterol metabolism in the human breast cancer cell lines MCF-7 and MDA-MB-231 using a genetic approach. Apolipoprotein A-I (apoA-I) and apolipoprotein E (apoE) were expressed in these cell lines to modulate cholesterol metabolism. The effects of these apolipoproteins on cancer cell properties were examined.
Results
Our results show that both apolipoproteins can regulate cholesterol metabolism and can control the epithelial-to-mesenchymal transition process. However, these effects were different depending on the cell type. We show that expressing apoA-I or apoE stimulates proliferation, migration, and tumor growth of MCF-7 cells. However, apoA-I or apoE reduces proliferation and migration of MDA-MB-231 cells.
Conclusions
These data suggest that modulating sterol metabolism may be most effective at limiting tumor progression in models of triple-negative cancers.
Funder
Ligue Contre le Cancer
Conseil Régional du Centre-Val de Loire
Publisher
Springer Science and Business Media LLC
Reference46 articles.
1. McPherson K, Steel CM, Dixon JM. APC of breast diseases: breast cancer-epidemiology, risk factors, and genetics. BMJ. 2000;321(7261):624–8.
2. Hilakivi-Clarke L, Wang C, Kalil M, Riggins R, Pestell RG. Nutritional modulation of the cell cycle and breast cancer. Endocr Relat Cancer. 2004;11(4):603–22.
3. Moorman PG, Hulka BS, Hiatt RA, Krieger N, Newman B, Vogelman JH, Orentreich N. Association between high-density lipoprotein cholesterol and breast cancer varies by menopausal status. Cancer Epidemiol Biomark Prev. 1998;7(6):483–8.
4. Kim Y, Park SK, Han W, Kim DH, Hong YC, Ha EH, Ahn SH, Noh DY, Kang D, Yoo KY. Serum high-density lipoprotein cholesterol and breast cancer risk by menopausal status, body mass index, and hormonal receptor in Korea. Cancer Epidemiol Biomark Prev. 2009;18(2):508–15.
5. Cauley JA, Zmuda JM, Lui LY, Hillier TA, Ness RB, Stone KL, Cummings SR, Bauer DC. Lipid-lowering drug use and breast cancer in older women: a prospective study. J Women’s Health (Larchmt). 2003;12(8):749–56.
Cited by
23 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献